Status:
COMPLETED
A Long-term Safety Study of Infliximab (Remicade)
Lead Sponsor:
Centocor, Inc.
Collaborating Sponsors:
Centocor BV
Conditions:
Arthritis, Rheumatoid
Crohn Disease
Eligibility:
All Genders
Brief Summary
This is a study evaluating the long-term safety of infliximab (Remicade)
Detailed Description
The purpose of this study is to collect long-term safety information on infliximab (Remicade) from patients who participate in research studies using those drugs. All patients in these studies are bei...
Eligibility Criteria
Inclusion
- All patients enrolled in ongoing and future Centocor sponsored infliximab clinical studies that require long-term safety follow-up (ie, primary studies). Patients must have received at least 1 dose of study agent to be eligible for participation in the study
Exclusion
- \- Did not previously participate in Centocor sponsored infliximab clinical studies.
Key Trial Info
Start Date :
February 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
2971 Patients enrolled
Trial Details
Trial ID
NCT00261976
Start Date
February 1 2002
End Date
March 1 2012
Last Update
March 18 2014
Active Locations (205)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States
2
Huntsville, Alabama, United States
3
Montgomery, Alabama, United States
4
Paradise Valley, Arizona, United States